Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) EBIT (2022 - 2025)

Historic EBIT for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$11.1 million.

  • InflaRx's EBIT rose 3432.13% to -$11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.8 million, marking a year-over-year increase of 1877.98%. This contributed to the annual value of -$57.4 million for FY2024, which is 1874.05% down from last year.
  • As of Q3 2025, InflaRx's EBIT stood at -$11.1 million, which was up 3432.13% from -$14.6 million recorded in Q2 2025.
  • Over the past 5 years, InflaRx's EBIT peaked at $8.67 during Q3 2022, and registered a low of -$16.9 million during Q3 2024.
  • Its 4-year average for EBIT is -$10.6 million, with a median of -$12.1 million in 2023.
  • Over the last 5 years, InflaRx's EBIT had its largest YoY gain of 9999.99% in 2023, and its largest YoY loss of 14008358198.44% in 2023.
  • Quarter analysis of 4 years shows InflaRx's EBIT stood at -$7.9 million in 2022, then plummeted by 82.27% to -$14.3 million in 2023, then rose by 27.13% to -$10.4 million in 2024, then decreased by 6.19% to -$11.1 million in 2025.
  • Its EBIT was -$11.1 million in Q3 2025, compared to -$14.6 million in Q2 2025 and -$13.7 million in Q1 2025.